CLINICAL_TRIALS ClinicalTrials.gov record update

An Adaptive, Operationally Seamless Phase II / III Study of 131I-apamistamab-Led Allogeneic Hematopoietic Stem Cell Transplant in Patients With Relapsed or Refractory Acute Myeloid Leukemia With Active Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07157514
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:20.979044+00:00
Published At: 2025-09-10T00:00:00+00:00
Record Updated At: 2025-09-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Leukemia", "Myeloid Leukemia", "Acute Myelogenous Leukemia", "Acute Myeloid Leukemia", "Acute Myeloid Leukemia, in Relapse", "Myelogenous Leukemia", "Myelogenous Leukemia, Acute", "Myelogenous Leukemia in Relapse", "Transplant-Related Disorder", "Allogeneic Disease", "Refractory AML"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-10"
protocolSection.identificationModule.nctId: "NCT07157514"
protocolSection.identificationModule.officialTitle: "An Adaptive, Operationally Seamless Phase II / III Study of 131I-apamistamab-Led Allogeneic Hematopoietic Stem Cell Transplant in Patients With Relapsed or Refractory Acute Myeloid Leukemia With Active Disease"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.